ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

Standard Surgical Protocol Improved Endometrial Staging

October 27, 2006

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

January 17, 2003

Breast Cancer Task Force Suggests 12 New Projects For RFPs, Hears Report On Hormones

January 16, 1976

In Brief: NCAB Committee Recommends Joint NCI/Vendor PDQ Promotion; Frank Schabel Dies In Vienna

September 9, 1983

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008